PLRX (PLRX) Stock Price & Analysis
PLRX (PLRX) rose 2.65% to USD 1.16 as of September 8, 2026 at 05:53 UTC, according to Nexqual real-time market data.
PLRX last closed at USD 1.16; the session ranged USD 1.11–1.18 on volume of 559,895 shares. Market capitalization is —, with a 52-week range of USD 1.02–1.95 (NMS). Source: Nexqual, September 8, 2026 at 05:53 UTC.
Key Statistics (as of September 8, 2026 at 05:53 UTC)
| Price | USD 1.16 |
|---|---|
| Change | ▲ 2.65% (up) |
| Previous Close | USD 1.16 |
| Open | USD 1.16 |
| Day Range | USD 1.11 – 1.18 |
| 52-Week Range | USD 1.02 – 1.95 |
| Volume | 559,895 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (PLRX)
Nexqual's technical model rates PLRX "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 05:53 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 56.41 (neutral) |
| vs SMA50 | Above (USD 1.11) |
| MACD | 0.01 (positive) |
From PLRX's Latest SEC 10-K Filing (filed 2026-03-11)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NKTX | Nkarta, Inc. | USD 2.92 | ▲ 5.61% |
| PASG | Passage Bio, Inc. | USD 4.65 | ▲ 0.87% |
| ORIC | Oric Pharmaceuticals, Inc. | USD 12.86 | ▼ 2.06% |
| PCVX | Vaxcyte, Inc. | USD 61.16 | ▼ 0.68% |
| STOK | Stoke Therapeutics, Inc. | USD 29.81 | ▼ 2.26% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:53 UTC. This page is informational and not investment advice.